The health and economic burden of bacteria is enormous.
Infectious diseases are the third deadliest disease group globally. In 3 decades, deaths from drug-resistant bacteria might exceed all cancers combined. Bacteria also compromises products performance and industrial efficiency. Financial costs mount up to tens of billions of dollars a year.
Bacteria live mostly in biofilm, which protect it from x1000 higher concentrations of disinfectants or antibiotics, let alone our immune system. Biofilm forms within hours, on almost any surface, but current approaches to prevent biofilm are short-term, toxic, induce bacterial-resistance, ineffective or inapplicable in many settings.
Nobio’s game-changing technology can transform this reality.